Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Double-blind Trial of Telotristat Etiprate in Carcinoid Syndrome
2013-001543-31Phase 3Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Carcinoid Syndrome (CS) comparing Telotristat etiprate with Placebo (2 arms). Primary endpoint: Change from Baseline in daily bowel movements. Started Sep 2013; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Carcinoid Syndrome (CS)
Beyond the preview
Go deeper on 2013-001543-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001543-31.